GCM
BVS icon

Graham Capital Management’s Bioventus BVS Stock Holding History

Graham Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,606
Closed -$179K – 1274
2026
Q1 		$179K Buy
+19,606
New +$164K ﹤0.01% 970
2025
Q3 		– Sell
-18,049
Closed -$119K – 1273
2025
Q2 		$119K Buy
18,049
+3,464
+24% +$24.6K ﹤0.01% 1194
2025
Q1 		$133K Buy
14,585
+574
+4% +$5.73K ﹤0.01% 1182
2024
Q4 		$147K Buy
+14,011
New +$166K ﹤0.01% 1117

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Graham Capital Management's BVS Position: Q2 2026 in Review

Graham Capital Management sold out of Bioventus (BVS) in Q2 2026, closing a stake of 19,606 shares — an estimated $179K sold.

Graham Capital Management first reported a position in BVS in Q4 2024 and held it in 4 quarters. The position peaked at $179K in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Graham Capital Management reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 19,606 Bioventus shares in Q2 2026, an estimated $179K.
  • Graham Capital Management first reported a position in Bioventus in Q4 2024 and held it in 4 quarters.
  • Graham Capital Management's Bioventus position peaked at $179K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.